Post-marketing access to orphan drugs: a critical analysis of health technology assessment and reimbursement decision-making considerations

Overview of attention for article published in Orphan Drugs: Research and Reviews, January 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)

Mentioned by

policy: 1 policy source
twitter: 5 X users

googleplus: 1 Google+ user

Citations

dimensions_citation: 22 Dimensions

Readers on

mendeley: 36 Mendeley

Summary Policy documents X Google+ Dimensions citations

So far, Altmetric has seen 1 Google+ post.

Dove Medical Press (NZ) Ltd, 28 Jan 2014

Post-marketing access to orphan drugs: a critical analysis of health technology assessment and reimbursement... Post-marketing…